Monday June 1, 2020

Vivasure gleans €16.2m funding to bring vascular closure device to EU and US

Innovative gadget eliminates need for open surgery and speeds recovery times

8th September, 2016
The Vivasure Vascular Closure device

Galway-based Vivasure Medical has completed a financing series worth €16.2 million.

The firm, which specialises in bio-absorbable technology for through-the-skin vessel closure, will use the funding to meet the growing demand for absorbable, percutaneous vessel closure products.

The round was led by Netherlands-based LSP and co-led by the German Evonik Venture Capital who came in alongside Panakès Partners of Italy with returning earlier investors led by Fountain Healthcare Partners in Ireland.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The former NTMA head says he is ‘quite alarmed’ at the potential for legal actions over the large number of deaths in nursing homes during the crisis

Michael Brennan | 4 weeks ago

Oil storage in the self-styled ‘Pipeline Crossroads of the World’ is full to the brim, but the black stuff keeps on coming. With much of the world’s economy in a Covid-19 slowdown, at one point last week, benchmark US crude oil was priced at minus $37.63 a barrel

Barry J Whyte | 1 month ago

Every time Donald Trump spoke on the Covid-19 crisis last week, the stock markets plunged by another point

Marion McKeone | 2 months ago